Cargando…

A meta-analysis of soluble suppression of tumorigenicity 2 (sST2) and clinical outcomes in pulmonary hypertension

Detalles Bibliográficos
Autores principales:	Luk, King Sum, Ip, Christina, Gong, Meng–Qi, Wong, Sunny Hei, Wu, William KK, Dong, Mei, Li, Guang–Ping, Chan, Ka Pang, Du, Yi–Mei, Liu, Tong, Wong, Martin CS, Hui, David Shu Cheong, Tse, Gary
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Science Press 2017
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5863055/ https://www.ncbi.nlm.nih.gov/pubmed/29581716 http://dx.doi.org/10.11909/j.issn.1671-5411.2017.12.007

Ejemplares similares

Soluble suppression of tumorigenicity 2 (sST2) for predicting disease severity or mortality outcomes in cardiovascular diseases: A systematic review and meta-analysis
por: Ip, Christina, et al.
Publicado: (2021)

Reference interval and the role of soluble suppression of tumorigenicity 2 (sST2) in subclinical cardiac dysfunction at health checkups
por: Nah, Eun‐Hee, et al.
Publicado: (2020)

Value of increased soluble suppressor tumorigenicity biomarker 2 (sST2) on admission as an indicator of severity in patients with COVID-19
por: Arnaldos-Carrillo, María, et al.
Publicado: (2023)

Differential and Predictive Value of Galectin-3 and Soluble Suppression of Tumorigenicity-2 (sST2) in Heart Failure with Preserved Ejection Fraction
por: Cui, Yameng, et al.
Publicado: (2018)

Prognostic Value of sST2 in Heart Failure
por: Sciatti, Edoardo, et al.
Publicado: (2023)

The IL-33/sST2 Axis in Thromboangiitis Obliterans
por: Sharebiani, Hiva, et al.
Publicado: (2020)

Sex and age differences in sST2 in cardiovascular disease
por: Beetler, Danielle J., et al.
Publicado: (2023)

sST2 and Heart Failure—Clinical Utility and Prognosis
por: Dudek, Magdalena, et al.
Publicado: (2023)

Cardiac Biomarkers in the Emergency Department: The Role of Soluble ST2 (sST2) in Acute Heart Failure and Acute Coronary Syndrome—There is Meat on the Bone
por: Aleksova, Aneta, et al.
Publicado: (2019)

Soluble IL-33 receptor sST2 inhibits colorectal cancer malignant growth by modifying the tumour microenvironment
por: Akimoto, Miho, et al.
Publicado: (2016)

The Association of Serum IL-33 and sST2 with Breast Cancer
por: Yang, Zhi-Ping, et al.
Publicado: (2015)

Serum sST2 levels predict severe exacerbation of asthma
por: Watanabe, Masato, et al.
Publicado: (2018)

Prognostic value of soluble suppression of tumorigenesis-2 (sST2) for cardiovascular events in coronary artery disease patients with and without diabetes mellitus
por: Li, Man, et al.
Publicado: (2021)

Association of Soluble Suppression of Tumorigenesis 2 (sST2) With Platelet Activation, Monocyte Tissue Factor and Ischemic Outcomes Following Angioplasty and Stenting
por: Stojkovic, Stefan, et al.
Publicado: (2020)

Could sST2 Predict Contrast-Induced Nephropathy in ST-Segment Elevation Myocardial Infarction?
por: Avcı, Ahmet, et al.
Publicado: (2020)

sST2 association with atrial fibrillation development in patients with acute myocardial infarction with ST elevation
por: Rodionova, I, et al.
Publicado: (2023)

Soluble Suppression of Tumorigenicity 2 and Echocardiography in Sepsis
por: Yang, Hyun Suk, et al.
Publicado: (2016)

Interdecadal variability in pan-Pacific and global SST, revisited
por: Tung, Ka-Kit, et al.
Publicado: (2018)

Increased levels of sST2 in patients with mitral annulus disjunction and ventricular arrhythmias
por: Scheirlynck, Esther, et al.
Publicado: (2019)

Non-cardiac Conditions Which Can Elevate The Serum Levels of sST2
por: Patil, T.R., et al.
Publicado: (2019)

Short-Term Prognosis Value of sST2 for an Unfavorable Outcome in Hypertensive Patients
por: Farcaş, Anca Daniela, et al.
Publicado: (2020)

Biomarkers of IL-33 and sST2 and Lack of Association with Carvedilol Therapy in Heart Failure
por: Firouzabadi, Negar, et al.
Publicado: (2020)

STADE‐HF (sST2 As a help for management of HF): a pilot study
por: Huet, Fabien, et al.
Publicado: (2020)

Diagnostic Value of sST2 in Cardiovascular Diseases: A Systematic Review and Meta-Analysis
por: Zhang, Tianyi, et al.
Publicado: (2021)

Alteration of the IL-33-sST2 pathway in hypertensive patients and a mouse model
por: Yin, Xiaoyun, et al.
Publicado: (2019)

The Clinical Significance of Serum IL-33 and sST2 Alterations in the Post-Stroke Depression
por: Xu, Meirong, et al.
Publicado: (2021)

Assessment of sST2 Behaviors to Evaluate Severity/Clinical Impact of Acute Pulmonary Embolism
por: Petramala, Luigi, et al.
Publicado: (2023)

A Review of Novel Cardiac Biomarkers in Acute or Chronic Cardiovascular Diseases: The Role of Soluble ST2 (sST2), Lipoprotein-Associated Phospholipase A2 (Lp-PLA2), Myeloperoxidase (MPO), and Procalcitonin (PCT)
por: Li, Junpei, et al.
Publicado: (2021)

Measurement of Interleukin-33 (IL-33) and IL-33 Receptors (sST2 and ST2L) in Patients with Rheumatoid Arthritis
por: Hong, Yeon-Sik, et al.
Publicado: (2011)

Diagnostic Value of Soluble Suppression of Tumorigenicity-2 for Heart Failure
por: Huang, Dong-Hui, et al.
Publicado: (2016)

Effects of liraglutide vs. lifestyle changes on soluble suppression of tumorigenesis-2 (sST2) and galectin-3 in obese subjects with prediabetes or type 2 diabetes after comparable weight loss
por: Simeone, Paola, et al.
Publicado: (2022)

Soluble Isoform of Suppression of Tumorigenicity 2 (ST2) Biomarker in a Large Cohort of Healthy Pediatric Population: Determination of Reference Intervals
por: Perrone, Marco Alfonso, et al.
Publicado: (2022)

Elevated Sera sST2 Is Associated With Heart Failure in Men ≤50 Years Old With Myocarditis
por: Coronado, Michael J., et al.
Publicado: (2019)

IL-33 and its decoy sST2 in patients with Alzheimer’s disease and mild cognitive impairment
por: Saresella, Marina, et al.
Publicado: (2020)

Prognostic Value of Circulating sST2 for the Prediction of Mortality in Patients With Cardiac Light-Chain Amyloidosis
por: Zhang, Yang, et al.
Publicado: (2021)

Clinical and prognostic relevance of sST2 in adults with dengue-associated cardiac impairment and severe dengue
por: Teo, Andrew, et al.
Publicado: (2022)

Significance of sTREM-1 and sST2 combined diagnosis for sepsis detection and prognosis prediction
por: Wei, Yongjun, et al.
Publicado: (2023)

The obesity-induced adipokine sST2 exacerbates adipose T(reg) and ILC2 depletion and promotes insulin resistance
por: Zhao, Xu-Yun, et al.
Publicado: (2020)

Evaluation of interleukin-33 & sST2 levels in type-2 diabetic mellitus patients with or without metabolic syndrome
por: Singh, Himadri, et al.
Publicado: (2023)

The pro-inflammatory marker soluble suppression of tumorigenicity-2 (ST2) is reduced especially in diabetic morbidly obese patients undergoing bariatric surgery
por: Demyanets, Svitlana, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_qlitqquk255cpr5v4dkhbc0oue